Regenxbio (RGNX) Revenue Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Revenue Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.83% |
| Sep 30, 2025 | -21.37% |
| Jun 30, 2025 | 5.21% |
| Mar 31, 2025 | 37.60% |
| Dec 31, 2024 | 12.51% |
| Sep 30, 2024 | 10.48% |
| Jun 30, 2024 | 22.62% |
| Mar 31, 2024 | 76.97% |
| Dec 31, 2023 | -11.44% |
| Sep 30, 2023 | 40.37% |
| Jun 30, 2023 | -12.98% |
| Mar 31, 2023 | -32.08% |
| Dec 31, 2022 | 72.71% |
| Sep 30, 2022 | 81.77% |
| Jun 30, 2022 | 37.84% |
| Mar 31, 2022 | 117.64% |
| Dec 31, 2021 | 198.01% |
| Sep 30, 2021 | 200.78% |
| Jun 30, 2021 | 56.13% |
| Mar 31, 2021 | 116.94% |